Neuroprotective Role Of Sulphate Among Preterm Babies (SuPreme Study)
Funder
National Health and Medical Research Council
Funding Amount
$749,338.00
Summary
Magnesium sulphate administered to mothers shortly before preterm birth, reduces the risk of cerebral palsy. The mechanism of its neuroprotective effect is unknown, and our studies suggest sulphate is the protective element. Preterm babies rapidly become sulphate deficient, and magnesium sulphate mitigates this deficiency in most infants. In this study we will investigate whether low blood sulphate levels at 1 week of age correlate with cerebral palsy.
Stuttering in childhood: Patterns of recovery and persistence. This project will benefit the 1 in 20 Australian children who stutter and their families. We will learn for the first time how stuttering impacts on child development in the early school years and document the relationship between stuttering and other childhood conditions. The study will produce much needed information about recovery from stuttering and stuttering persistence. Therefore new knowledge will result to inform the scienti ....Stuttering in childhood: Patterns of recovery and persistence. This project will benefit the 1 in 20 Australian children who stutter and their families. We will learn for the first time how stuttering impacts on child development in the early school years and document the relationship between stuttering and other childhood conditions. The study will produce much needed information about recovery from stuttering and stuttering persistence. Therefore new knowledge will result to inform the scientific community and provide professionals and families with much needed evidence-based information about stuttering progression. Together this information will inform intervention approaches and help direct resources to those children who need them most. Read moreRead less